Goal 3
GOAL 3 is a social enterprise founded in 2019, dedicated to improving healthcare systems worldwide by empowering health workers and developing innovative, cost-effective medical solutions. Their mission is to enable and empower 1 million health workers by 2030 to improve access to high-quality care for 100 million people, focusing on low-resource settings. They develop and implement the IMPALA system, an end-to-end clinical support system including vital sign monitors, a clinical app, and a service package, to shift healthcare from reactive to proactive, saving lives and reducing workload. The organization also established the GOAL 3 Foundation in 2023 to support the implementation of IMPALA in hospitals that cannot afford it, emphasizing sustainable, impact-driven healthcare solutions.
Industries
Nr. of Employees
small (1-50)
Goal 3
Headoffice GOAL 3, Grasso Building; Room KA1.14, Parallelweg 27, 5223 AL, 's Hertogenbosch, The Netherlands
Products
Integrated clinical monitoring solution (monitor, app, server)
End-to-end clinical monitoring system consisting of a fit-for-context continuous vital-sign monitor, a clinical support application and a server for data storage, sharing and analysis designed for low-resource hospitals.
Integrated clinical monitoring solution (monitor, app, server)
End-to-end clinical monitoring system consisting of a fit-for-context continuous vital-sign monitor, a clinical support application and a server for data storage, sharing and analysis designed for low-resource hospitals.
Services
On-site installation, clinical and technical training for hospital staff, and integration of monitoring workflows.
Provision of consumables/spares and establishment of local repair teams to maintain device uptime.
Design and execution support for observational and validation studies to evaluate device performance and clinical impact.
Collection, curation and analysis of monitoring data to train predictive models and integrate analytics into clinical software.
Management of foundation-backed donation flows, coordination of procurement and installation funded by donors, and provision of impact reporting to donors about deployed monitors and hospital-level outcomes.
Conducting cost-effectiveness calculations and outcome analysis to inform scale-up decisions and donor communications.
On-site installation, clinical and technical training for hospital staff, and integration of monitoring workflows.
Provision of consumables/spares and establishment of local repair teams to maintain device uptime.
Design and execution support for observational and validation studies to evaluate device performance and clinical impact.
Collection, curation and analysis of monitoring data to train predictive models and integrate analytics into clinical software.
Management of foundation-backed donation flows, coordination of procurement and installation funded by donors, and provision of impact reporting to donors about deployed monitors and hospital-level outcomes.
Conducting cost-effectiveness calculations and outcome analysis to inform scale-up decisions and donor communications.
Expertise Areas
- Clinical trial management and pilot studies in low-resource settings
- Continuous vital-sign monitoring for pediatric and neonatal wards
- Machine learning and predictive analytics for deterioration detection
- Clinical data pipelines and dataset curation for algorithm training
Key Technologies
- Continuous multi-parameter vital-sign monitoring
- Server/cloud-based real-time analytics and data storage
- Machine learning predictive algorithms
- Ballistography and bed-pressure sensing
News & Updates
GOAL 3's IMPALA system was awarded the iF Design Award in Berlin, recognizing its functional and aesthetic design.
The European Commission awarded GOAL 3 with a 150,000 euro EU Prize for Humanitarian Innovation for the IMPALA system, recognizing its potential as a highly cost-effective health intervention.
In January 2023, GOAL 3 implemented the IMPALA system at St. Lukes Hospital in Malawi, leading to significant reductions in mortality and admission time.
GOAL 3 received a grant to implement the IMPALA system at Sengerema Hospital in Tanzania, starting in July 2023, with plans to implement 17 systems across departments.
GOAL 3's IMPALA system received a $260,000 grant from Founders Pledge to validate its cost-effectiveness, which could outperform traditional interventions by up to 20 times.
GOAL 3's IMPALA system was awarded the iF Design Award in Berlin, recognizing its functional and aesthetic design.
GOAL 3's IMPALA system was awarded the iF Design Award in Berlin, recognizing its functional and aesthetic design.
The European Commission awarded GOAL 3 with a 150,000 euro EU Prize for Humanitarian Innovation for the IMPALA system, recognizing its potential as a highly cost-effective health intervention.
In January 2023, GOAL 3 implemented the IMPALA system at St. Lukes Hospital in Malawi, leading to significant reductions in mortality and admission time.
GOAL 3 received a grant to implement the IMPALA system at Sengerema Hospital in Tanzania, starting in July 2023, with plans to implement 17 systems across departments.
GOAL 3's IMPALA system received a $260,000 grant from Founders Pledge to validate its cost-effectiveness, which could outperform traditional interventions by up to 20 times.
GOAL 3's IMPALA system was awarded the iF Design Award in Berlin, recognizing its functional and aesthetic design.